A Research Study to Evaluate the Safety and Tolerability of SGC001 in Healthy Subjects

NCT07079618 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Anterior Myocardial Infarction

Interventions

DRUG: SGC001
DRUG: Placebo

Sponsor

Beijing Sungen Biomedical Technology Co., Ltd